Serra-Baldrich, E.
Santamaría-Babí, L.F.
Francisco Silvestre, J.
This article is maintained by: Elsevier
Article Title: Nemolizumab: un innovador tratamiento biológico para el control de la interleuquina 31 (IL-31) clave en la dermatitis atópica y el prurigo nodular
Journal Title: Actas Dermo-Sifiliográficas
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2021.12.014
Content Type: article
Copyright: © 2021 AEDV. Published by Elsevier España, S.L.U.